Sheikh, Mohammed Hussen and Hazazi, Ahlam Shary J. and Alanazi, Ashwaq Nafea O. and Hazazi, Ibtisam Shary J. and Qaysi, Amal Abutaleb M. and Alali, Yara Abdulrahman and Alshehri, Badaya Awadh M. and Almutari, Ohoud Abdullah and Bedaiwi, Rawan Hamdi and Alatawi, Rawan Hamoud M. and Alqarni, Rahf Mohammed and Alharbi, Alanoud Abdullah and Alshehri, Rawan Ahmed H. and Alrashidi, Rinad Rasheed M. and Al Balawi, Mona Awad O. (2021) Overview on Causes and Updated Management of Favism. Journal of Pharmaceutical Research International, 33 (47B). pp. 249-254. ISSN 2456-9119
3909-Article Text-5727-1-10-20221006.pdf - Published Version
Download (171kB)
Abstract
Favism is most common in those who have G6PD deficiency from the Mediterranean region. As hemolytic anaemia is the most common complication of G6PD deficiency, and it can be life-threatening in certain people. Infection, hyperglycemia, certain meals, and certain drugs can all cause hemolysis therefore, the most prevalent enzymopathy is glucose-6-phosphate dehydrogenase (G6PD) deficiency, which affects an estimated 400 million individuals, globally. Exposure to some medicines might cause hemolytic anaemia. The most important management technique is to avoid oxidative stresses by avoiding a hemolytic crisis. Also, avoidance of exposure to food and medicines that causes hemolytic anaemia episodes
This review looks at etiology, epidemiology, pathopysiology, evaluation and management of the disease.
Item Type: | Article |
---|---|
Subjects: | Library Keep > Medical Science |
Depositing User: | Unnamed user with email support@librarykeep.com |
Date Deposited: | 25 Jan 2023 11:31 |
Last Modified: | 02 Jan 2024 13:15 |
URI: | http://archive.jibiology.com/id/eprint/24 |